Navidea Biopharmaceuticals (NYSE: NAVB) Precision Immunodiagnostics, a Game Changer for Patients and Physicians

From The QualityStocks Daily Blog for Micro-cap and Small-Cap Companies
May 9, 2017 - 8:54am
Precision medicine and precision diagnostics in particular play a major role in today’s medical world, by helping patients and physicians detect various diseases in time, which in turn allows for the proper treatments and care to be prescribed. Companies such as Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) are at the forefront of precision medicine, developing […]


Continue reading this article »